COVID-19 may have lost its daily news headline status, but the disease rages on with 2700 weekly deaths in the U.S. and millions of Americans chronically...
BioVaxys and Procare Health Execute US Distribution Agreement for Papilocare Gel and Oral Immunocaps Canada NewsWire VANCOUVER, British Colombia and BARCELONA, Spain, Dec. 19, 2022 VANCOUVER,...
KAZIA LAUNCHES PRECLINICAL COLLABORATION WITH QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE AND ANNOUNCES PATENT FILING PR Newswire SYDNEY, Dec. 15, 2022 SYDNEY, Dec. 15, 2022 /PRNewswire/ -- Kazia...
Toronto, Ontario – Thenewswire – December 14, 2022 – Helix BioPharma Corp. (TSX:HBP), (“Helix” or the “Company”), a clinical-stage biopharmaceutical...
Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with Favipiravir Canada NewsWire MONTREAL, Dec. 6, 2022 The combination of ARDS-003 and Favipiravir presents...
Vancouver, BC / December 1, 2022 / Universal Ibogaine Inc. (the “Company”) (TSXV: IBO) is pleased to announce that it has closed its non-brokered...
Oncolytics Biotech® Receives FDA Fast Track Designation for the Treatment of Advanced/Metastatic Pancreatic Cancer Canada NewsWire SAN DIEGO, and CALGARY, AB, Dec. 1, 2022 FDA Fast...
COMPELLING PRECLINICAL DATA FOR KAZIA'S EVT801 PUBLISHED IN PEER-REVIEWED CANCER RESEARCH JOURNAL PR Newswire SYDNEY, Dec. 1, 2022 SYDNEY, Dec. 1, 2022 /PRNewswire/ -- Kazia Therapeutics...
PsyBio Therapeutics Reports Third Quarter 2022 Financial Results Canada NewsWire OXFORD, Ohio and DENVER, Nov. 29, 2022 OXFORD, Ohio and DENVER, Nov. 29, 2022 /CNW/ – PsyBio Therapeutics...
Toronto, Ontario--(Newsfile Corp. - November 17, 2022) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma Bright" or the "Company"), developer of...